Black Swan Sale

50% Off Elite

Register Now!

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

Last Close
Nov 21  •  04:00PM ET
100.22
Dollar change
+1.94
Percentage change
1.97
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y15.46% Total Holdings27 Perf Week1.38%
SponsorVan Eck Associates Corporation ETF Type Tagsequity Return% 3Y12.38% AUM1.14B Perf Month8.36%
Fund Family Bond Type Tagshealthcare Return% 5Y10.46% NAV/sh Perf Quarter14.02%
IndexMVIS US Listed Pharmaceutical 25 Index Average Maturity Tagspharmaceutical Return% 10Y 52W High100.46 -0.24% Perf Half Y16.13%
Index Weighting Commodity Type Tags- Return% SI 52W Low77.67 29.03% Perf YTD16.16%
Active/Passive Quant Type Tags- Flows% 1M-12.62% Volatility1.57% 1.45% Perf Year15.37%
Dividend TTM1.94 (1.93%) ESG Type Tags- Flows% 3M73.50% ATR (14)1.43 Perf 3Y36.80%
Dividend Ex-DateOct 01, 2025 Dividend Type Sector/Theme Flows% YTD64.69% RSI (14)74.35 Perf 5Y53.38%
Dividend Gr. 3/5Y10.99% 8.51% Structure Type Region Flows% 1Y Beta0.45 Perf 10Y59.71%
Expense0.36% Growth/Value SMA204.69% Flows% 3Y Rel Volume0.87 Prev Close98.28
Inverse/Leveraged Market Cap SMA507.95% Flows% 5Y Avg Volume542.40K Price100.22
IPODec 21, 2011 Option/ShortYes / Yes SMA20012.17% Trades Volume473,725 Change1.97%
Nov-14-25 07:59AM
Nov-10-25 07:47AM
Oct-16-25 03:14AM
Oct-13-25 06:10AM
Oct-10-25 06:09PM
06:57AM Loading…
Oct-06-25 06:57AM
Oct-01-25 11:10AM
Sep-26-25 01:05PM
09:24AM
Sep-22-25 06:20AM
Aug-19-25 06:15AM
Aug-08-25 11:00AM
Jul-22-25 06:20AM
Jul-17-25 11:00AM
Jul-01-25 06:20AM
06:20AM Loading…
Jun-18-25 06:20AM
May-21-25 06:20AM
May-15-25 10:00AM
May-13-25 08:00AM
May-12-25 12:52PM
10:30AM
May-09-25 06:20AM
May-08-25 11:50AM
May-02-25 03:25AM
Apr-30-25 04:35AM
Apr-28-25 06:20AM
Apr-23-25 05:45AM
Apr-18-25 01:40PM
Apr-17-25 06:20AM
Apr-16-25 10:00AM
09:15AM Loading…
Apr-14-25 09:15AM
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-29-25 12:50AM
Mar-28-25 06:05AM
Mar-20-25 04:32PM
06:20AM
Dec-20-24 08:56PM
Sep-20-22 03:13PM
Mar-26-22 10:00PM
Jan-24-22 01:38PM
Dec-14-21 10:38PM
May-22-20 07:46AM
May-18-20 10:03AM
Apr-09-20 10:10AM
Feb-07-20 11:05AM
Jan-22-20 01:00PM
Dec-20-19 08:10AM
Dec-05-19 03:34PM
Nov-22-19 05:15PM
Nov-08-19 08:00AM
Nov-06-19 11:00AM
Sep-30-19 06:04PM
Sep-23-19 11:27AM
Sep-09-19 02:09PM
Aug-22-19 11:12AM
Aug-07-19 10:59AM
Jun-28-19 06:01PM
Jun-26-19 11:00AM
Jun-25-19 06:01PM
May-14-19 05:40PM
May-09-19 10:05AM
Apr-30-19 12:59PM
Mar-29-19 06:42PM
Mar-21-19 07:56AM
Feb-21-19 10:08AM
Feb-07-19 11:15AM
Jan-29-19 09:08AM
Jan-07-19 09:27AM
Dec-26-18 06:37PM
Dec-14-18 09:28AM
Dec-10-18 10:33AM
Nov-16-18 05:52PM
Oct-24-18 11:59AM
Oct-17-18 11:48AM
Oct-12-18 06:00AM
Oct-09-18 11:39AM
Sep-28-18 06:03PM
Jul-03-18 03:19PM
Jun-29-18 06:15PM
Jun-04-18 10:38AM
Apr-24-18 06:41AM
Mar-29-18 05:58PM
Jan-25-18 09:00AM
07:31AM
Jan-22-18 10:00AM
07:34AM
Jan-15-18 10:31AM
Jan-10-18 12:03PM
Jan-09-18 10:31AM
Jan-08-18 07:33AM
Jan-05-18 10:35AM
Dec-26-17 06:15PM
Nov-22-17 05:30PM
Nov-14-17 02:35PM
Oct-16-17 12:33PM
Oct-02-17 12:35PM
Sep-29-17 05:25PM
Sep-20-17 10:36AM
VanEck Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.